Detailed data on COVID-19 vaccination progress in the EU/EEA available via Vaccine Tracker and in weekly reports
Vaccination campaigns against COVID-19 disease are well under way in all EU/EEA countries, and more detailed information is now available on the ECDC website.
Stress test on logistical aspects of COVID-19 vaccination deployment plans: final report
ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans. Twelve EU/EEA Member States participated in this stress test, a focused simulation exercise conducted in two rounds, one in mid-December 2020 and the second in early January 2021.
Monitoring COVID-19 vaccination progress across Europe
Following the conditional marketing authorisation and deployment of the first COVID-19 vaccines in the EU/EEA, all countries have started vaccination campaigns by vaccinating people in priority groups. To monitor the progress of vaccination efforts across the EU/EEA, ECDC has set up a monitoring system for collection of key vaccine rollout indicators.
COVID-19 vaccination and prioritisation strategies in the EU/EEA
This document builds on a previously published ECDC report, ‘Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK’ . By using mathematical modelling, this document provides EU/EEA countries with information on factors that may affect the choice of COVID-19 vaccination
ECDC releases COVID-19 vaccination rollout strategies for EU/EEA
On 22 December ECDC released the technical report titled ‘COVID-19 vaccination and prioritisation strategies in the EU/EEA’, following the European Medicines Agency (EMA) recommendation for authorisation of the vaccine Comirnaty, developed by BioNTech and Pfizer.
Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK
This document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). The aim is to support but not define EU policy on COVID-19 vaccination.
Prevention of human rabies: A challenge for the European Union and the European Economic Area
Gossner, C.M., Mailles, A., Aznar, I., Dimina, E., Echevarria, J.E., Feruglio, S.L., Lange, H., Maraglino, F.P., Parodi, P., Perevoscikovs, J., Van der Stede, Y., Bakonyi, T.
Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/ EEA countries and the United Kingdom, January to May 2020
Nicolay, N., Mirinaviciute, G., Mollet, T., Celentano, L.P., Bacci, S.
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.